TT125-802

· Tolremo Therapeutics AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TT125-802, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors [Phase 1]

See pricing